Biosynthesized silver nanoparticles: are they effective antimicrobials?

AUTOR(ES)

Peiris, Mudara K, Gunasekara, Chinthika P, Jayaweera, Pradeep M, Arachchi, Nuwan DH, Fernando, Neluka

FONTE

Mem. Inst. Oswaldo Cruz

DATA DE PUBLICAÇÃO

2017-08

RESUMO

BACKGROUND Silver nanoparticles (AgNPs) are increasingly being used in medical applications. Therefore, cost effective and green methods for generating AgNPs are required. OBJECTIVES This study aimed towards the biosynthesis, characterisation, and determination of antimicrobial activity of AgNPs produced using Pseudomonas aeruginosa ATCC 27853. METHODS Culture conditions (AgNO3 concentration, pH, and incubation temperature and time) were optimized to achieve maximum AgNP production. The characterisation of AgNPs and their stability were evaluated by UV-visible spectrophotometry and scanning electron microscopy. FINDINGS The characteristic UV-visible absorbance peak was observed in the 420–430 nm range. Most of the particles were spherical in shape within a size range of 33–300 nm. The biosynthesized AgNPs exhibited higher stability than that exhibited by chemically synthesized AgNPs in the presence of electrolytes. The biosynthesized AgNPs exhibited antimicrobial activity against Escherichia coli, P. aeruginosa, Salmonella typhimurium, Staphylococcus aureus, methicillin-resistant S. aureus, Acinetobacter baumannii, and Candida albicans. MAIN CONCLUSION As compared to the tested Gram-negative bacteria, Gram-positive bacteria required higher contact time to achieve 100% reduction of colony forming units when treated with biosynthesized AgNPs produced using P. aeruginosa.

Documentos Relacionados

• Impact of biosynthesized silver nanoparticles on protein and carbohydrate contents in seeds of Pisum sativum L.
• New hybrid material based on layered double hydroxides and biogenic silver nanoparticles: antimicrobial activity and cytotoxic effect
• Effective Health Care bulletins: are they efficient?
• Diazepam-Loaded Solid Lipid Nanoparticles: Design and Characterization
• Public health programmes will have to prove they are cost effective